Figure 3From: Simplified approaches for the development of an ELISA to detect circulating autoantibodies to p53 in cancer patientsELISA experiment showing reactivity of three different sources of p53 antigen to various commercial antibodies. The purified (His)6-p53 fusion protein 1 μg/ml (A) and (His)6-p53 fusion protein 100 μg/ml directly immobilized onto nickel coated microtiter plate (B) were subjected to react with various amounts of anti-p53 mAb (0, 1:10000, 1:5000 and 1:1000 dilution) and anti-histidine mAb (1:1000 dilution). The p53-BCCP fusion protein directly immobilized onto avidin-coated microtiter plate were reacted with various amounts of anti-p53 mAb (0, 1:10,000, 1:5,000 and 1:1,000 dilution) and anti-biotin mAb (1:1000 dilution). Experiment was performed in triplicate and error bars represent standard deviation.Back to article page